Inventor

Qing Dong

Inventor
San Diego, CA, US

Overview

68→
Patents
2001–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 68 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
A61KPreparations for medical, dental or toiletry purposes20%
C07CAcyclic or carbocyclic compounds2%
LOC132%
H04LTransmission of digital information, e.g. telegraphic communication2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
G05FSystems for regulating electric or magnetic variables1%
H02JElectric power networks1%
H02MApparatus for conversion between ac and ac, between ac and dc, or between dc and dc, and for use with mains or similar power supply systems1%
PatentTitleYear
11,053,219Substituted pyridines as TYK2 inhibitors202111,040,972Autotaxin inhibitors and uses thereof202111,034,671Apoptosis signal-regulating kinase inhibitors and uses thereof2021D0911933Battery2021D0910547Battery2021D0910546Battery2021D0910548Battery202110,787,430Hemoglobin modifier compounds and uses thereof202010,759,788Pharmaceutical uses of pyridine carboxamide derivatives202010,711,000Autotaxin inhibitors and uses thereof202010,633,388Pyrazolopyrimidone derivatives and methods of use thereof202010,537,555Complex of angiotensin receptor antagonist and neutral endopeptidase inhibitor202010,442,794Processes for preparing pyridine carboxamide derivatives201910,428,074Pyrrole heteroaryl ring derivative and method of use thereof201910,364,234Pyridinecarboxamide derivatives, preparation method thereof and pharmaceutical uses thereof201910,344,034Pyrazolopyrimidone or Pyrrolotriazone derivatives, method of preparing same, and pharmaceutical applications thereof201910,310,537Variation-tolerant voltage reference201910,285,590Intraocular pressure sensor with improved voltage reference circuit201910,277,118Charge pump circuit and method of operating same201910,081,629Amide derivatives and pharmaceutically acceptable salts thereof, preparation method thereof and medicinal application thereof201810,005,781Pyrazolopyrimidone or pyrrolotriazone derivatives, method of preparing same, and pharmaceutical applications thereof20189,987,7073D print apparatus and method utilizing friction stir welding20189,895,355'Methods of treating androgen receptor-mediated disorders with imidazoline derivatives'20189,787,176'Charge pump'20179,637,484'Cycloalkyl acid derivative, preparation method thereof, and pharmaceutical application thereof'20179,586,947'Imidazoline derivatives, preparation methods thereof, and their applications in medicine'20179,527,851'Pyrrole six-membered heteroaryl ring derivative, preparation method thereof, and medicinal uses thereof'20169,388,133'Pyrrole sulfonamide derivative, preparation method for same, and medical application thereof'20169,181,255'Fused heteroaromatic pyrrolidinones as SYK inhibitors'20159,139,548'Polycyclic derivatives, preparation process and pharmaceutical use thereof'20159,108,970'Fused heteroaromatic pyrrolidinones'20159,096,294'Trolley-payload inter-ship transfer system'20159,045,496'N-substituted oxazinopteridines and oxazinopteridinones'20158,791,107'N-substituted oxazinopteridines and oxazinopteridinones'20148,785,429'Dihydropyrrolonaphthyridinone compounds as inhibitors of JAK'20148,769,315'Power managing energy-harvesting for selectively controlling a state of individual computer based on a harvesting energy stored available'20148,609,622'C-aryl glucoside derivatives, preparation process and pharmaceutical use thereof'20138,600,566'Thermal management smart valve with rupture detection and isolation'20138,594,572'Wireless electric power transmission through wall'20138,509,060'Active-avoidance-based routing in a wireless ad hoc network'20138,470,837'MAPK/ERK kinase inhibitors'20138,440,689'Fused heteroaromatic pyrrolidinones'20138,420,816'Dihydropyrrolonaphthyridinone compounds as inhibitors of JAK'20138,318,939'Kinase inhibitors'20128,293,901'MAPK/ERK kinase inhibitors'20128,288,536'Kinase inhibitors'20128,278,450'Kinase inhibitors'20128,268,819'Hexahydrooxazinopterine compounds'20128,260,911'Scheduling method for polling device data'20128,163,755'Hexahydrooxazinopterine compounds'20128,119,655'Kinase inhibitors'20128,088,783'MAPK/ERK kinase inhibitors'20128,063,066'MAPK/ERK kinase inhibitors'20118,030,317'MAPK/ERK kinase inhibitors'20118,022,057'MAPK/ERK kinase inhibitors'20117,943,659'MAPK/ERK kinase inhibitors'20117,943,626'Substituted 1,3-dialkyl-2,4-dioxo-6-(pyridylamino)-1,2,3,4-tetrahydropyrimidine-5-hydroxamic acid inhibitors of MAPK/ERK kinase'20117,855,288'Pyrrolo [1,2-d] [1,2-4] triazine as inhibitors of c-Jun N terminal kinases (JNK) and p-38 kinases'20107,760,585'Through the bulkhead repeater'20107,713,973'Kinase inhibitors'20107,696,218'Substituted 1,3-dialkyl-2,4-dioxo-6-(arylamino)-1,2,3,4-tetrahydropyrimidine-5-hydroxamic acid inhibitors of MAPK/ERK kinase'20107,652,044'P-38 inhibitors'20107,653,490'Nuclear magnetic resonance assembly of chemical entities'20107,569,571'Substituted pyrazolo [3,4-d]pyrimidines as cytokine modulators'20097,433,949'Scheduling method for polling device data'20087,011,676'Flat knitted stent and method of making the same'20066,593,347'Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use'20036,297,260'Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use'2001

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2009–2021Based in San Diego, CA, US· patent location history
2010–2015Patents assigned to TAKEDA PHARMACEUTICAL (21)· patent assignee history
2010–2015Based in Birdsboro, PA, US· patent location history
2011–2018Patents assigned to DONG QING (22)· patent assignee history
2012–2014Patents assigned to SCORAH NICHOLAS (8)· patent assignee history
2013–2020Patents assigned to JIANGSU HENGRUI MEDICINE CO (14)· patent assignee history
2013–2020Based in Shanghai, CN· patent location history
2016–2020Patents assigned to Shanghai hengrui pharmaceutical co ltd (12)· patent assignee history
2017–2019Based in Ann Arbor, MI, US· patent location history
2021Based in Dongguan, CN· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
DONG QINGself222011–2018
TAKEDA PHARMACEUTICAL212010–2015
JIANGSU HENGRUI MEDICINE CO142013–2020
Shanghai hengrui pharmaceutical co ltd122016–2020
SCORAH NICHOLAS82012–2014
Locations
LocationPatentsSpan
San Diego, California, US312009–2021
Shanghai, CN142013–2020
Birdsboro, Pennsylvania, US62010–2015
Dongguan, CN42021
Ann Arbor, MI, US42017–2019